
StarchTek
OperatingStarchTek Corp.
Software & AI · Wilmington, CA · Founded 2020
Replacing plastics with biomaterials
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Principal holders% as the filing states it, May 1, 2023
- John D Danny910,000 Common Stock85.0%of company
Sold to the crowd
- Reg CF · Jun 202212,249 shares at $10.00$122.5K· 82 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
3 people
Born in Argentina, raised in Northern California by Slavic parents to be an entrepreneur that eventually will use his early experience to help future immigrants adapt to the US financial system. Mr. Dubuk started working at his father’s machine shop at age 14 where he learned how to be a machinist, program CNC machines and learned all the functional areas of business during those 11 years. By age 25, Mr. Dubuk received a Bachelor of Science & MBA and began his finance career in the life insurance industry during the junk bond climb and eventual demise. Ever the solution provider, Mr. Dubuk shortly thereafter started his own boutique investment banking firm (Accord Financial Services “AFS”) that grew to $50MM AUM, mainly from high net worth entrepreneurs looking for i) High Yield Life Insurance Strategies, ii) Direct Lending Opportunities: Subprime-RE/Subprime-Auto/Factoring/Lease-Paper, iii) Government Redevelopment Capital and iv) Strategic Business Development & Funding By 2004, 16 years later, Mr. Dubuk moved into operations of the then thriving market; Subprime-Auto. Mr. Dubuk Co-founded Integrity Capital Management “ICM”) which focused on the Houston used automobile market. The ICM team led by Mr. Dubuk placed, managed, and grew the portfolio to $30MM from private investors and Wall Street capital. As the “2009 global nuclear financial winter” arrived, Wall street went into hibernation and the equity partners elected to run off the portfolio for self-preservation reasons. Having a good understanding of the immigrant underserved market, Mr. Dubuk then engaged with Fundamo LTD to bring mobile payment services to the unbanked US market. Specifically, the large money transmitting corridor between Hawaii and the Philippines by partnering with a prepaid phone carrier in Hawaii and G-Cash in the Philippines, to overpay the phone bill and remit the difference back home. VISA acquired Fundamo in 2011. Thereafter, Mr. Dubuk applied his skills and experience in working with startups in the Sustainable Foods and Cold Chain Packaging Markets holding the position of CFO, SVP-Strategy & Finance and at times, the de-facto CEO and raising over $35MM in equity capital at valuations as high as $40MM. Hence, Mr. Dubuk brings the experience and knowledge to understand and leverage the key drivers the market and the investment world is looking for in all functional areas of a business: Finance, Accounting, Human Resources, Legal, Marketing, Sales, Public Relations, Business Development, Supply Chain, Manufacturing, Engineering, R&D, Investor Relations. Mr. Dubuk offers a unique skill set with his mathematical and creative talents together with his manufacturing, investment, operations and multiple asset class experience and global strategic networks, for companies that are looking to grow.

Kerry Coltun has over 35 years of experience in the process technology industry. Early in his career, he was responsible for process development research activities focusing on the commercial manufacturing of ethical pharmaceuticals. He subsequently transitioned to the biotechnology industry where he was responsible for managing technology teams involved with clinical stage manufacturing efforts. His diverse process technology experiences have included development of cutting-edge automation schemes over a wide cross section of industries inclusive of chemical manufacturing, power and energy generation, and clean technology initiatives. Mr. Coltun currently serves as the Director of Process and Automation for a major engineering and technology firm located in northern California. He graduated with a BS degree in Chemical Engineering from Purdue University, and a MS degree in Engineering from University of Wisconsin-Madison. He is currently a licensed Professional Engineer in the State of California and is a Certified Automation Professional through the International Society of Automation.

Dr. Graham has over 46 years of experience as a chief scientific officer with responsibilities to control internal and external (University) R & D programmers, working with multinational customers on applications and developments, working with environmental groups in the USA, Europe and the Far East, setting up and working with distributors in Europe and the Far East, working with the ASTM D 20.96 committee for degradable plastics, quality control, patent developments, presentations of the technology at conferences and meetings in the USA, Europe and the Far East and Technologies included destructurized starch extrudable plastic compounds, polyvinyl alcohol extrusion, co-extrusion and solubility, biodegradation of polyolefins, vinyl alcohol and polyesters, plastics processing, including film blowing and casting, injection molding, bottle blowing, fiber extrusion, compounding of various polymers including biodegradable ones, and manufacture of degradable non-wovens. Dr. Graham currently serves as a Consulting in the field of specialty plastics, particularly biodegradable and water-soluble plastics, waste management and novel materials. Client companies in the UK, USA, Canada, Germany, Middle East, Denmark the Director of Process and Automation for a major engineering and technology firm located in northern California. He graduated with a MA from Cambridge University in Organic Chemistry/Natural/Sciences/Chemistry/Mathematics/Biochemistry and Physics. He also hold a Ph.D. degree from Imperial College in London in Organic Chemistry. He is a Member of ASTM D20.96 Committee for Degradable Plastics
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.